Invention Grant
- Patent Title: Multispecific antibody platform and related methods
-
Application No.: US15542781Application Date: 2016-08-03
-
Publication No.: US10538595B2Publication Date: 2020-01-21
- Inventor: Wenjun Zhang
- Applicant: BISON THERAPEUTICS INC.
- Applicant Address: US NJ Princeton
- Assignee: BISON THERAPEUTICS, INC.
- Current Assignee: BISON THERAPEUTICS, INC.
- Current Assignee Address: US NJ Princeton
- Agency: Gearhart Law, LLC
- International Application: PCT/US2016/045325 WO 20160803
- International Announcement: WO2017/034770 WO 20170302
- Main IPC: C07K16/46
- IPC: C07K16/46 ; C07K16/28 ; C07K16/32 ; A61K47/64 ; A61K47/68 ; C07K16/06

Abstract:
Novel multispecific antibody platform, multispecific antibodies and a method to make the antibodies is disclosed here. The CH3 domain harboring polypeptide chains of the Fc-regions are modified by increasing the positive charge of one chain and negative charge of another chain. Heterodimer formation in cotransfection with the modified chains is comparable to formation of wild type antibodies when same cell line is transfected with wild type polypeptides. Moreover, the modification provides a simple one step purification of the heterodimers.
Public/Granted literature
- US20190119406A1 MULTISPECIFIC ANTIBODY PLATFORM AND RELATED METHODS Public/Granted day:2019-04-25
Information query